company coverage
Sionna Therapeutics, Inc. research (NASDAQ:SION)
Coverage of Sionna Therapeutics, Inc. collects dated research on business quality, return drivers, balance-sheet resilience, valuation scenarios, and what would change the thesis for NASDAQ:SION.
1 edition linked in this hub.
Coverage
- 11 Aug 2026A 15-patient trial wiped out Sionna's platform premium. Cash now exceeds market valueSionna Therapeutics (NASDAQ:SION) fell 91.2% after SION-719 missed its key activity endpoint. We test what cash protects after the platform reset.